Molecular biology of pituitary tumors

被引:1
|
作者
Al-Shraim, M
Al-Gahtany, M
Al-Otaibi, M
Al-Ahmari, A
Scheithauer, BW
Lloyd, RV
Kovacs, K
机构
[1] Univ Toronto, St Michaels Hosp, Div Pathol, Dept Lab Med & Pathobiol, Toronto, ON M5B 1W8, Canada
[2] Univ Toronto, Toronto Western Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada
[3] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
来源
ENDOCRINOLOGIST | 2004年 / 14卷 / 06期
关键词
pituitary; adenoma; tumorigenesis; clonality; oncogenes; tumor suppressor genes;
D O I
10.1097/01.ten.0000146243.82774.76
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pituitary neoplasms are relatively common tumors that demonstrate a wide range of hormonal and proliferative behaviours. The diversity in their hormonal activity reflects their complex cytodifferentiation. It was believed that 1 cell of adenohypophysis could produce only 1 hormone. However, advances in immunocytochemistry, electron microscopy, and molecular studies have led to a new classification of pituitary tumors and a better understanding of the mechanisms that determine development of these neoplasms. The heterogeneity of pituitary adenoma subtypes suggested that no single common etiologic event was responsible for the development of adenoma. Molecular studies within the last decade have provided evidence that multiple molecular events are involved in the pathogenesis of pituitary adenomas. These series of molecular events supported the modem theory of multistep tumorigenesis. The objective of this review is to shed light on the molecular pathogenesis and histologic classification of adenohypophyseal neoplasms based on the recent biochemical results, molecular studies, and clinicopathologic findings. Understanding the genetic defects of pituitary tumors allows a deeper insight in the pathogenesis and biologic behaviour of pituitary tumors and can lead to the development of a novel approach for the management of patients with pituitary tumors.
引用
收藏
页码:359 / 367
页数:9
相关论文
共 50 条
  • [21] Molecular Biology of Renal Cortical Tumors
    Klatte, Tobias
    Pantuck, Allan J.
    UROLOGIC CLINICS OF NORTH AMERICA, 2008, 35 (04) : 573 - 580
  • [22] Molecular biology of nervous system tumors
    Rempel, SA
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2001, 15 (06) : 979 - +
  • [23] The genetics and molecular biology of neural tumors
    S Brandner
    British Journal of Cancer, 2010, 102 (4) : 784 - 785
  • [24] Molecular biology of spindle cell tumors
    Guillou, L
    UPDATE IN PATHOLOGY, PROCEEDINGS, 2003, : 459 - 462
  • [25] Molecular biology and the treatment of brain tumors
    Schiffer, D
    GIORNALE DI NEUROPSICOFARMACOLOGIA, 1998, 20 (06): : 203 - 203
  • [26] THE MOLECULAR-BIOLOGY OF UROLOGICAL TUMORS
    TRAPMAN, J
    PROSTATE, 1992, : 159 - 169
  • [27] Molecular biology of lipomatous and myxoid tumors
    Coindre, JM
    UPDATE IN PATHOLOGY, PROCEEDINGS, 2003, : 458 - 459
  • [28] MOLECULAR-BIOLOGY OF UROLOGICAL TUMORS
    RUSSELL, PJ
    BROWN, JL
    GRIMMOND, SM
    RAGHAVAN, D
    BRITISH JOURNAL OF UROLOGY, 1990, 65 (02): : 121 - 130
  • [29] Insights into the molecular biology of adrenocortical tumors
    Groussin, L.
    Bertherat, J.
    Gicquel, C.
    le Bouc, Y.
    Bertagna, X.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 (03) : 175 - 178
  • [30] Exploring stem cell biology in pituitary tumors and derived organoids
    Nys, Charlotte
    Lee, Yu-Lun
    Roose, Heleen
    Mertens, Freya
    De Pauw, Ellen
    Kobayashi, Hiroto
    Sciot, Raf
    Bex, Marie
    Versyck, Georges
    De Vleeschouwer, Steven
    Van Loon, Johannes
    Laporte, Emma
    Vankelecom, Hugo
    ENDOCRINE-RELATED CANCER, 2022, 29 (07) : 427 - 450